Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in Adults with Hematologic Malignancies: A Phase III, Randomized Clinical Trial

DOI: 10.1093/ofid/ofx163.1040

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text